OTTAWA, Jan. 17, 2012 /CNW/ - The following is a statement by Russell Williams, President of Canada's
Research-Based Pharmaceutical Companies (Rx&D) on the Council of
Federation announcement today to establish a new Health Care Innovation
Working Group led by Prince Edward Island Premier Robert Ghiz and
Saskatchewan Premier Brad Wall.
"Canada's Research-Based Pharmaceutical Companies welcome the direction
taken by the Premiers and Territorial leaders to create a new Health
Care Innovation Working Group.
"At Rx&D, we believe that innovation is essential to sustainable health
care in Canada. With the rise of chronic disease and an aging
population, all governments are grappling with unprecedented demand for
health care services. It is clear that we face a collective challenge
to sustain our health care system where traditional approaches no
"We commend the Council of Federation's commitment to fully engage in
this process. An innovation agenda in health care will leverage the
value of new ideas, products and processes; maximize efficiencies; and,
focus upstream with a serious and sustained approach to chronic disease
prevention and management.
"Pharmaceutical innovation is a proven tool to help Canadians live
longer, healthier, more productive lives. It is critical to the future
productivity of our country, our workplaces, our communities and our
citizens. Innovation is also the life-blood of a sustainable health
care system and crucial for "patient-centered" care.
"The development of new and more effective medicines and vaccines
continues to change the face of health care in Canada. Canadians now
survive life threatening illness or live with chronic conditions in
ways not possible for previous generations. Consider how different life
is today for Canadians living with HIV/AIDS, diabetes or those who rely
on medication to manage risk factors for heart disease and stroke.
"We look forward to working with the Premiers across Canada to develop
and implement a scientific innovation and knowledge agenda that will
result in better health and greater prosperity."
Rx&D is the association of leading research-based pharmaceutical
companies dedicated to improving the health of Canadians through the
discovery and development of new medicines and vaccines. Our community
represents 15,000 men and women working for 50 member companies and
invests more than $1 billion in research and development each year to
fuel Canada's knowledge-based economy. Guided by our Code of Ethical
Practices, our membership is committed to working in partnership with
governments, healthcare professionals and stakeholders in a highly
SOURCE CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX
For further information: